These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15734949)

  • 1. The critical role of risk-benefit assessments in cancer prevention.
    Hawk E; Viner JL
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):297-8. PubMed ID: 15734949
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemopreventive agent development research program in the Division of Cancer Prevention of the US National Cancer Institute: an overview.
    Crowell JA
    Eur J Cancer; 2005 Sep; 41(13):1889-910. PubMed ID: 16005206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer prevention I: introduction.
    Dunn BK; Greenwald P
    Semin Oncol; 2010 Jun; 37(3):190-201. PubMed ID: 20709204
    [No Abstract]   [Full Text] [Related]  

  • 5. Lycopene in cancer prevention and treatment.
    Seren S; Lieberman R; Bayraktar UD; Heath E; Sahin K; Andic F; Kucuk O
    Am J Ther; 2008; 15(1):66-81. PubMed ID: 18223356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results and perspectives in the chemoprophylaxis of cancer].
    Aleksandrov VA
    Vopr Onkol; 1997; 43(1):124-9. PubMed ID: 9133079
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention clinical trials: it is time to turn success into progress.
    Brown PH
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoprevention: from research to clinical oncology.
    Veronesi U; Bonanni B
    Eur J Cancer; 2005 Sep; 41(13):1833-41. PubMed ID: 16061373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Chemopreventive Agents: Drug Development Status II.
    J Cell Biochem Suppl; 1996; 26():1-321. PubMed ID: 9221292
    [No Abstract]   [Full Text] [Related]  

  • 11. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
    Vanchieri C
    J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical development plan: l-Selenomethionine.
    J Cell Biochem Suppl; 1996; 26():202-18. PubMed ID: 9154178
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview: the late Larry C. Clark showed the bright side of the moon element (selenium) in a clinical cancer prevention trial.
    el-Bayoumy K
    Nutr Cancer; 2001; 40(1):4-5. PubMed ID: 11799921
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical development plan: sulindac sulfone.
    J Cell Biochem Suppl; 1996; 26():227-35. PubMed ID: 9154180
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of advanced prostate cancer--new drugs.
    Ullén A; Shah CH; Kirkali Z
    Acta Oncol; 2011 Jun; 50 Suppl 1():137-40. PubMed ID: 21604954
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical development plan: 13-cis-retinoic acid.
    J Cell Biochem Suppl; 1996; 26():168-201. PubMed ID: 9154177
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical development plan: vitamin A.
    J Cell Biochem Suppl; 1996; 26():269-307. PubMed ID: 9154183
    [No Abstract]   [Full Text] [Related]  

  • 18. Lycopene in the prevention of prostate cancer.
    Dahan K; Fennal M; Kumar NB
    J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk factors and prevention of cancer of various localizations (part 1)].
    Belialova NS; Belialov FI
    Klin Med (Mosk); 2005; 83(11):17-21. PubMed ID: 16404933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.